Literature DB >> 33709783

Ischemia-modified albumin in gynecology.

Mehmet F Kıncı1, Burcu Kasap1, Ahmet A Sivaslıoğlu1.   

Abstract

Background: Ischemia-modified albumin (IMA) is an oxidative stress marker used to assess the presence and severity of oxidative stress. This marker was first used for early diagnosis of myocardial ischemia. Materials & methods: A variety of IMA studies were carried out to show the effect of oxidative stress on gynecological disorders.
Conclusion: This analysis summarizes the literature by conducting electronic research on the relationship between IMA and gynecological disorders.

Entities:  

Keywords:  IVF; PCOS; endometriosis; gynecology; ischemia-modified albumin; menopause; oxidative stress

Mesh：

Substances：

Year:  2021        PMID： 33709783     DOI： 10.2217/bmm-2020-0616

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


  2 in total

1.  Serum IMA and LP-PLA2 Levels in Patients with Coronary Heart Disease and Their Correlation with the Degree of Myocardial Ischaemia and Their Diagnostic Value.

Authors:  Likui Zhang; Zipeng Li; Ning Li
Journal:  Emerg Med Int       Date:  2022-06-11       Impact factor: 1.621

Review 2.  Ischemia-Modified Albumin: Origins and Clinical Implications.

Authors:  Alla Shevtsova; Iuliia Gordiienko; Viktoriia Tkachenko; Galyna Ushakova
Journal:  Dis Markers       Date:  2021-07-19       Impact factor: 3.434
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.